Article
β-arrestin 2 mediates cardiac ischemia-reperfusion injury via inhibiting GPCR-independent cell survival signalling.
Cardiovascular research - 1 Nov 2017
Wang Yimei, Jin Li, Song Ying, Zhang Mao, Shan Dan, Liu Yuli, Fang Meng, Lv Fengxiang, Xiao Rui-Ping, Zhang Yan
Abstract excerpt
AIMS: Ischemic heart disease is a leading cause of morbidity and mortality worldwide. Although timely restoration of coronary blood flow (reperfusion) is the most effective therapeutics of myocardial infarction, reperfusion causes further cardiac damage, i.e. ischemia-reperfusion (I/R) injury. β-arrestins (Arrbs) have been traditionally defined as negative regulators of G protein-coupled receptor (GPCR)...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
